Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 13:14:1329729.
doi: 10.3389/fonc.2024.1329729. eCollection 2024.

Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country

Affiliations

Challenges in treating children with optic pathway gliomas: an 18-year experience from a middle-income country

Jorge Luis Ramírez-Melo et al. Front Oncol. .

Abstract

Introduction: Patients with optic pathway gliomas (OPG) have good survival rates although their long-term quality of life can be affected by the tumor or treatment-related morbidity. This retrospective study sought to describe the clinical presentation and outcomes of children with OPG at a tertiary center in Mexico.

Methods: Consecutive patients <18 years-of-age with newly diagnosed OPG between January 2002 and December 2020 at the Hospital Civil de Guadalajara Dr. Juan I. Menchaca in Guadalajara, Mexico were included.

Results: Thirty patients were identified with a median age of six years. The most frequent clinical manifestations were loss of visual acuity (40%) and headaches (23%). Neurofibromatosis-1 was found in 23.3% of the patients. Surgery, either biopsy or resection, was done in 20 of 30 patients. Two patients died shortly after initial surgery. The 5-year event-free survival (EFS) was 79.3% ± 10.8% and the 5-year overall survival was 89.5% ± 6.9%. Lower EFS was associated with age less than 3 years, intracranial hypertension at presentation, and diencephalic syndrome. Patients who received surgery as first-line treatment had a 3.1 times greater risk of achieving a performance score of less than 90 points at 6 months after diagnosis (p=0.006). Of 10 patients with vision testing, 5 had improvement in visual acuity, 4 had no changes, and one patient showed worsening.

Conclusion: Our data suggests that favorable outcomes can be achieved with OPG in low- and middle-income countries, although a high rate of surgical complications was described leading to a lower overall survival. These data can be used prospectively to optimize treatment at this institute and other middle-income countries through a comprehensive, multidisciplinary approach.

Keywords: global oncology; low-and middle-income countries; low-grade glioma; optic pathway glioma; visual acuity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Swimmer’s plot of cohort.
Figure 2
Figure 2
Outcome of pediatric OPG in Mexico. (A) EFS; (B) OS; (C) EFS based on age; (D) EFS based on presence of increased intracranial pressure (ICP) at presentation; (E) EFS based presence of diencephalic syndrome (DS); (F) EFS based on treatment. CT, chemotherapy.

Similar articles

Cited by

  • Resources for the practice of pediatric neuro-oncology in Mexico: a cross-sectional evaluation.
    Arce-Cabrera D, Escamilla-Asiain G, Nájera-Castillo MF, Navarro-Martín Del Campo RM, Ortiz-Azpilcueta M, Pantoja-Guillén FJ, Arreguín González FE, Zapata-Sosa I, Lugo-Juárez JZ, Santillán Cortéz D, Morales-La Madrid A, Moreira DC, Benito-Reséndiz AE. Arce-Cabrera D, et al. Front Oncol. 2024 Jun 21;14:1330705. doi: 10.3389/fonc.2024.1330705. eCollection 2024. Front Oncol. 2024. PMID: 38974245 Free PMC article.

References

    1. Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. . International incidence of childhood cancer, 2001-10: a population-based registry study. Lancet Oncol (2017) 18(6):719–31. doi: 10.1016/S1470-2045(17)30186-9 - DOI - PMC - PubMed
    1. Ostrom QT, Price M, Neff C, Cioffi G, Waite KA, Kruchko C, et al. . CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020. Neuro Oncol (2023) 25(Supplement_4):iv1–iv99. doi: 10.1093/neuonc/noad149 - DOI - PMC - PubMed
    1. Walker DA, Aquilina K, Spoudeas H, Pilotto C, Gan HW, Meijer L. A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences. Front Pediatr (2023) 11:1038937. doi: 10.3389/fped.2023.1038937 - DOI - PMC - PubMed
    1. Massimino M, Spreafico F, Cefalo G, Riccardi R, Tesoro-Tess JD, Gandola L, et al. . High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol (2002) 20(20):4209–16. doi: 10.1200/JCO.2002.08.087 - DOI - PubMed
    1. Grabenbauer GG, Schuchardt U, Buchfelder M, Rödel CM, Gusek G, Marx M, et al. . Radiation therapy of optico-hypothalamic gliomas (OHG)–radiographic response, vision and late toxicity. Radiother Oncol (2000) 54(3):239–45. doi: 10.1016/S0167-8140(00)00149-3 - DOI - PubMed